CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with ...
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
MPM BioImpact Appoints Brian Shuster, Experienced in Healthcare Corporate Development, as Entrepreneur Partner
MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver ...
Le Lézard1h
Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets
Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces its intentions to broaden its platform capabilities to enable production of a wider range of test ...
Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance
Raises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, Adjusted EBITDA of $755 - $805 million, Representing YoY Growth of 24% - 32%, ...
Le Lézard1h
Holiday Slowdown Arrives in December with Some Silver Linings For Buyers
December 2024 saw a 22.0% growth in homes actively for sale compared with the same time last year, according to the December Monthly Housing Trends Report from Realtor.com®. Miami (45.4%), San Diego ...
24/7 Wall St1h
Merck Just Paid Investors: How Much Did They Receive?
Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...
North American Summit, In2 SABRE Awards Return To Chicago, February 19
CHICAGO-PRovoke Media's North American Summit-including the In2 SABRE Awards-is returning to Chicago as a standalone event ...
The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing
The T1D Fund, an impact investment fund with a focus on accelerating life-changing solutions to treat, prevent, and cure type ...
FierceBiotech2h
LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push
Bristol Myers Squibb’s Cobenfy achieved an 8.4-point PANSS improvement over placebo after five weeks in a phase 3 trial that ...
PharmiWeb2h
Cambridge Cognition highlights positive CANTAB® results in research by Bristol Myers Squib
Cambridge Cognition Holdings plc (AIM: COG), the brain health software group, congratulates Bristol Myers Squibb, the global biopharmaceutical company, for its recent FDA approval of Cobenfy (KarXT™ ...
Brain Ischemia Market Grow At CAGR Of 7.6% Growth, Reaching $1,622 Million By 2032 Globally
Global Brain Ischemia market Size, Share & Trends Analysis Report By treatment (Angioplasty, Beta Blockers, Angiotensin-Converting Enzyme (ACE) In ...